The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years.
CMS has determined that those beneficiaries who are 55-77, asymptomatic, have a tobacco smoking history of at least 30 pack-years, are a current smoker or one who has quit smoking within the last 15 years; and receives a written order for LDCT lung cancer screening may receive an annual screening for lung cancer with low-dose computed tomography (LDCT), as an additional preventive service benefit under the Medicare program. CMS: Decision Memo for Screening for Lung Cancer with Low- Dose Computed Tomography (LDCT) (CAG-00439N).
The Low-Dose CT (LDCT) Lung Cancer Screening Option (LCS) for qualified GE Systems is indicated for using low-dose CT for lung cancer screening. The screening must be performed within the established inclusion criteria of programs/protocols that have been approved and published by either a governmental body or professional medical society.
The National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011;365:395-409. https://www.nejm.org/doi/full/10.1056/NEJMoa1102873
